IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
Agnes Trautmann,Olivia Boyer,Elisabeth Hodson,Arvind Bagga,Debbie S. Gipson,Susan Samuel,Jack Wetzels,Khalid Alhasan,Sushmita Banerjee,Rajendra Bhimma,Melvin Bonilla-Felix,Francisco Cano,Martin Christian,Deirdre Hahn,Hee Gyung Kang,Koichi Nakanishi,Hesham Safouh,Howard Trachtman,Hong Xu,Wendy Cook,Marina Vivarelli,Dieter Haffner,Antonia Bouts,Claire Dossier,Francesco Emma,Markus Kemper,Rezan Topaloglu,Aoife Waters,Lutz Thorsten Weber,Alexandra Zurowska,Keisha L. Gibson,Larry Greenbaum,Susan Massengill,David Selewski,Tarak Srivastava,Chia-shi Wang,Scott Wenderfer,Lilian Johnstone,Nicholas Larkins,William Wong,Agnes A. Alba,T. S. Ha,Masoumeh Mokham,Xuhui Zhong,Riku Hamada,Kazumoto Iijima,Kenji Ishikura,Kandai Nozu,Nilzete Bresolin,Nilka De Jesus Gonzalez,Jaime Restrepo,Ifeoma Anochie,Mignon McCulloch,
DOI: https://doi.org/10.1007/s00467-022-05739-3
2022-10-21
Pediatric Nephrology
Abstract:Abstract Idiopathic nephrotic syndrome is the most frequent pediatric glomerular disease, affecting from 1.15 to 16.9 per 100,000 children per year globally. It is characterized by massive proteinuria, hypoalbuminemia, and/or concomitant edema. Approximately 85–90% of patients attain complete remission of proteinuria within 4–6 weeks of treatment with glucocorticoids, and therefore, have steroid-sensitive nephrotic syndrome (SSNS). Among those patients who are steroid sensitive, 70–80% will have at least one relapse during follow-up, and up to 50% of these patients will experience frequent relapses or become dependent on glucocorticoids to maintain remission. The dose and duration of steroid treatment to prolong time between relapses remains a subject of much debate, and patients continue to experience a high prevalence of steroid-related morbidity. Various steroid-sparing immunosuppressive drugs have been used in clinical practice; however, there is marked practice variation in the selection of these drugs and timing of their introduction during the course of the disease. Therefore, international evidence-based clinical practice recommendations (CPRs) are needed to guide clinical practice and reduce practice variation. The International Pediatric Nephrology Association (IPNA) convened a team of experts including pediatric nephrologists, an adult nephrologist, and a patient representative to develop comprehensive CPRs on the diagnosis and management of SSNS in children. After performing a systematic literature review on 12 clinically relevant PICO (Patient or Population covered, Intervention, Comparator, Outcome) questions, recommendations were formulated and formally graded at several virtual consensus meetings. New definitions for treatment outcomes to help guide change of therapy and recommendations for important research questions are given.
pediatrics,urology & nephrology